Back
Revance Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
RVNC
Revance Therapeutics
Last Price:
$3.07
Seasonality Move:
-2.77%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.
Revance Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.07 | Buy |
| 20-day SMA: | 3.46 | Sell |
| 50-day SMA: | 4.37 | Sell |
| 200-day SMA: | 4.37 | Sell |
| 8-day EMA: | 3.14 | Sell |
| 20-day EMA: | 3.46 | Sell |
| 50-day EMA: | 4.1 | Sell |
| 200-day EMA: | 5.56 | Sell |
Revance Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 33.1 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.14 - 3.96) | Sell |
| Bollinger Bands (100): | (3.74 - 6.28) | Sell |
Revance Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Revance Therapeutics Stock
Is Revance Therapeutics Stock a Buy?
-
Revance Therapeutics share price is 3.08 while RVNC 8-day simple moving average is 3.07, which is a Buy signal.
-
The stock price of RVNC is 3.08 while Revance Therapeutics 20-day SMA is 3.46, which makes it a Sell.
-
Revance Therapeutics 50-day simple moving average is 4.37 while RVNC share price is 3.08, making it a Sell technically.
-
RVNC stock price is 3.08 and Revance Therapeutics 200-day simple moving average is 4.37, creating a Sell signal.
RVNC Technical Analysis vs Fundamental Analysis
Sell
13
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy or a Sell?
-
Revance Therapeutics stock is rated a SellThe current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Revance Therapeutics Stock Info
Market Cap:
323.1M
Price in USD:
3.08
Share Volume:
3.5M
Revance Therapeutics 52-Week Range
52-Week High:
9.75
52-Week Low:
2.30
Sell
13
Revance Therapeutics (RVNC)
is a Sell
Revance Therapeutics Share Price Forecast
-
What is the Revance Therapeutics stock price today?The Revance Therapeutics stock price is 3.08 USD today.
-
Will RVNC stock go up or go down?Revance Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Revance Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Revance Therapeutics is overvalued.
Is Revance Therapeutics Stock a Buy?
-
Revance Therapeutics share price is 3.08 while RVNC 8-day exponential moving average is 3.14, which is a Sell signal.
-
The stock price of RVNC is 3.08 while Revance Therapeutics 20-day EMA is 3.46, which makes it a Sell.
-
Revance Therapeutics 50-day exponential moving average is 4.10 while RVNC share price is 3.08, making it a Sell technically.
-
RVNC stock price is 3.08 and Revance Therapeutics 200-day simple moving average is 5.56, creating a Sell signal.
Fundamental Analysis of Revance Therapeutics
Is Revance Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.
Technical Analysis of Revance Therapeutics
Should I short Revance Therapeutics stock?
-
RVNC Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Revance Therapeutics is a Sell
-
Revance Therapeutics Relative Strength Index (RSI) is 33.1, which suggest Revance Therapeutics is oversold
-
The Bollinger Bands (25) for Revance Therapeutics is (3.14 - 3.96), which suggest Revance Therapeutics is a Sell
-
The Bollinger Bands (100) for Revance Therapeutics is (3.74 - 6.28), which suggest Revance Therapeutics is a Sell
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.